The Swiss voice in the world since 1935

Tobacco consumption costs Switzerland CHF5 billion a year

smoking
Overall most of the smoking-related deaths (44%) were due to cancer. © Keystone / Christian Beutler

Smoking alone is responsible for almost 4% of the country’s medical bill and 14% of deaths, according to a Swiss study.  

A research study published on Monday by the Zurich University of Applied Sciences estimates that in 2015 tobacco consumption generated direct medical costs of CHF3 billion ($3.03 billion). This can be broken up into CHF1.2 billion for the treatment of cancer, CHF1 billion for cardiovascular diseases and CHF0.7 billion for respiratory illnesses.  

In addition, the Swiss economy loses around CHF2 billion a year due to illness and premature death among the workforce as a result of tobacco consumption.  

In 2015, tobacco consumption in Switzerland caused a total of 9,535 deaths, or 14.1% of all deaths in that year. By way of comparison: in the same year, 253 people died in road accidents and 2,500 died as a result of the flu. 

Men accounted for just under two-thirds (64%) of tobacco-related deaths and overall most of the smoking-related deaths (44%) were due to cancer. Other common causes of death among smokers were cardiovascular as well as lung and respiratory diseases, with 35% and 21% of deaths respectively.  

Smokers aged 35 to 54 were fourteen times more likely to die from lung cancer than non-smokers within the same age group.  

The study was commissioned by the Swiss Association for Smoking Prevention. The Swiss parliament is due to discuss regulations on tobacco advertising in the autumn session. 

More


Popular Stories

Most Discussed

News

Pharmaceutical companies do not plan job cuts in Switzerland

More

US tariffs: Pharma firms not planning job cuts in Switzerland

This content was published on The additional investments in the US will not lead to a reduction in jobs in Switzerland. This is according to pharmaceutical giant Roche, which expects the number of employees to remain stable in the current year. The position of Novartis is similar.

Read more: US tariffs: Pharma firms not planning job cuts in Switzerland
Very close" exchanges between Berne and the business world

More

Swiss government working with firms to overcome high US tariffs

This content was published on The Swiss delegation that travelled to Washington has returned from talks on tariffs in the United States. The negotiations are now being conducted under the aegis of the government and the federal administration, according to Seco.

Read more: Swiss government working with firms to overcome high US tariffs
WTO improves its world trade forecast thanks to Trump

More

WTO improves its world trade forecast thanks to Trump’s tariffs

This content was published on The World Trade Organisation (WTO) expects world trade to grow by 0.9% this year, better than expected in April. US imports surged in the first quarter as a result of Donald Trump's tariff announcements.

Read more: WTO improves its world trade forecast thanks to Trump’s tariffs
Gold exporters wait, the metal may not be taxed

More

Swiss gold exports might not face US tariffs after all

This content was published on Gold exports to the United States may not be taxed after all. The White House plans to "issue an executive order in the near future to clarify misinformation regarding the taxation of gold bullion," among other things.

Read more: Swiss gold exports might not face US tariffs after all

In compliance with the JTI standards

More: SWI swissinfo.ch certified by the Journalism Trust Initiative

You can find an overview of ongoing debates with our journalists here . Please join us!

If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.

SWI swissinfo.ch - a branch of Swiss Broadcasting Corporation SRG SSR

SWI swissinfo.ch - a branch of Swiss Broadcasting Corporation SRG SSR